Aandeel ENZN ENZON PHARMACEUTICALS, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Enzon Pharmaceuticals, Inc.

Aandelen

ENZN

US2939041081

Beurs gesloten - OTC Markets
Andere beurzen
 20:10:36 26-06-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,1863 USD +23,29% Intraday-grafiek van Enzon Pharmaceuticals, Inc. +24,20% +99,04%
10/05 Enzon Pharmaceuticals, Inc. rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024 CI
20/03 Enzon Pharmaceuticals, Inc. rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
ENZON PHARMACEUTICALS, INC. : Other Events (form 8-K)
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
ENZON PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers ENZN
  4. Nieuws Enzon Pharmaceuticals, Inc.
  5. Andere talen